- €632.27m
- €677.72m
- €821.80m
- 81
- 47
- 29
- 50
2019 December 31st | 2020 December 31st | R2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | Interim Report | ARS | ARS |
Standards: | IFRS | IFRS | — | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 667 | 637 | 608 | 755 | 822 |
Cost of Revenue | |||||
Gross Profit | 236 | 212 | 210 | 264 | 284 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 600 | 579 | 558 | 709 | 775 |
Operating Profit | 67.3 | 57.1 | 50 | 46.6 | 47.2 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 66.6 | 39.6 | 48.1 | 43.2 | 42.9 |
Provision for Income Taxes | |||||
Net Income After Taxes | 52 | 32.3 | 35.2 | 34.2 | 30 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 52 | 32.3 | 55.1 | 37.1 | 18.9 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 52 | 32.3 | 55.1 | 37.1 | 18.9 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.85 | 1.1 | 1.25 | 1.21 | 1.04 |
Dividends per Share |